STOCK OPTION AGREEMENT United States Participants (ISO/NSO)Stock Option Agreement • March 29th, 2024 • Akari Therapeutics PLC • Pharmaceutical preparations • New York
Contract Type FiledMarch 29th, 2024 Company Industry JurisdictionAGREEMENT made as of the date of the grant set forth in Exhibit A (the “Effective Date”) by and between Akari Therapeutics, Plc, a company formed under the laws of England and Wales, and having a place of business at 22 Boston Wharf Road, Floor 7, Boston, MA 02210, USA (the “Company”) and the individual whose name and address appears under his or her signature below (the “Participant”).
STOCK OPTION AGREEMENT United States Participants (NSO)Stock Option Agreement • March 29th, 2024 • Akari Therapeutics PLC • Pharmaceutical preparations • New York
Contract Type FiledMarch 29th, 2024 Company Industry JurisdictionAGREEMENT made as of the date of the grant set forth in Exhibit A (the “Effective Date”) by and between Akari Therapeutics, Plc, a company formed under the laws of England and Wales, and having a place of business at 22 Boston Wharf Road, Floor 7, Boston, MA 02210, USA (the “Company”) and the individual whose name and address appears under his or her signature below (the “Participant”).